[144] CoreWeave, Inc. SEC Filing

Rhea-AI Filing Summary

Form 144 notice for CoreWeave, Inc. (CRWV) shows a proposed sale of 1,000,000 shares of common stock through Goldman Sachs & Co. LLC, with an aggregate market value of $99,970,000 and an approximate sale date of 08/15/2025. The shares were acquired as Founder Shares on 09/21/2017 and the filer reports no cash payment arrangements for the original acquisition. The filing also discloses multiple related-party sales on 08/14/2025 totaling several million shares across trusts and an LLC, with gross proceeds reported for each sale. The filer certifies they do not possess undisclosed material adverse information about the issuer.

Positive

• Full disclosure of proposed and recent sales including dates, seller names, amounts, and gross proceeds
• Origin of shares clearly stated (Founder Shares acquired 09/21/2017) for the proposed sale

Negative

• Large recent dispositions by multiple trusts and an LLC on 08/14/2025 totaling several million shares as reported
• Planned sale by a founder of 1,000,000 shares with an aggregate market value of $99,970,000

Insights

Securities Analyst

TL;DR: Insiders are selling multiple millions of shares across entities; a separate founder sale of 1,000,000 shares is scheduled.

The Form 144 lists a proposed sale of 1,000,000 founder shares via Goldman Sachs with an indicated market value of $99,970,000 and an expected sale date of 08/15/2025. The filing also records actual sales on 08/14/2025 by several trusts and an LLC totaling several million shares with reported gross proceeds per seller. These disclosures indicate sizable offloading of common stock by related parties and a founder, all explicitly documented in the notice.

Corporate Governance Expert

TL;DR: Multiple entity-level dispositions and a founder's planned sale are formally disclosed; the filer affirms no undisclosed material adverse information.

The notice identifies the nature of acquisition as Founder Shares for the 1,000,000 shares proposed to be sold and provides seller names, dates, and gross proceeds for recent sales by trusts and an LLC on 08/14/2025. The signature statement reiterates standard legal attestation regarding material information. All points are reported directly in the filing without additional commentary.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Goldman Sachs & Co. LLC 200 West Street New York NY 10282	1000000	99970000	370470348	08/15/2025	NASD

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	09/21/2017	Founder Shares	The Issuer			1000000	09/21/2017	None

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Coconut Tree Trust 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common Stock	08/14/2025	120000	10866000
Apple Tree Trust 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common Stock	08/14/2025	120000	10866000
CW Holding 987 LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common Stock	08/14/2025	2556000	231445800
Birch Tree Trust LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common Stock	08/14/2025	111000	10051050
Willow Tree Trust LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common Stock	08/14/2025	111000	10051050
Maple Tree Trust LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common Stock	08/14/2025	111000	10051050
Chestnut Tree Trust LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common Stock	08/14/2025	111000	10051050

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for CoreWeave (CRWV) disclose about the proposed sale?

The notice discloses a proposed sale of 1,000,000 common shares via Goldman Sachs with an aggregate market value of $99,970,000 and an approximate sale date of 08/15/2025.

When and how were the shares being sold by the filer originally acquired?

The 1,000,000 shares to be sold were acquired as Founder Shares on 09/21/2017, with no cash payment arrangements noted for that acquisition in the filing.

Were there any recent related-party sales disclosed in the filing?

Yes. The filing lists multiple sales on 08/14/2025 by Coconut Tree Trust, Apple Tree Trust, CW Holding 987 LLC, and several other trusts, with amounts and gross proceeds reported for each seller.

Who is the broker named for the proposed sale?

The broker named in the Form 144 for the proposed sale is Goldman Sachs & Co. LLC located at 200 West Street, New York, NY.

Does the filer assert possession of any undisclosed material information about CoreWeave?

By signing the form, the filer represents that they do not know any material adverse information regarding the issuer that has not been publicly disclosed.